Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis

被引:14
|
作者
Kloosterman, Marielle [1 ]
Oldgren, Jonas [2 ]
Conen, David [3 ]
Wong, Jorge A. [3 ]
Connolly, Stuart J. [3 ]
Avezum, Alvaro [4 ]
Yusuf, Salim [3 ]
Ezekowitz, Michael D. [5 ]
Wallentin, Lars [2 ]
Ntep-Gweth, Marie [6 ]
Joseph, Philip [3 ]
Barrett, Tyler W. [7 ]
Tanosmsup, Supachai [8 ]
McIntyre, William F. [3 ]
Lee, Shun Fu [3 ]
Parkash, Ratika [9 ,10 ]
Amit, Guy [3 ]
Grinvalds, Alex [3 ]
Van Gelder, Isabelle C. [1 ]
Healey, Jeff S. [3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Uppsala Univ, Dept Med Sci, Uppsala Clin Res Ctr, Uppsala, Sweden
[3] McMaster Univ, Populat Hlth Res Inst, Dept Med, 30 Birge St,Room C3-121, Hamilton, ON L8L 0A6, Canada
[4] Dante Pazzanese Inst Cardiol, Div Cardiol, Sao Paulo, Brazil
[5] Med Coll & Lankenau Med Ctr, Dept Med, Wynnewood, PA USA
[6] Hop Cent Yaounde, Dept Med, Yaounde, Cameroon
[7] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[8] Mahidol Univ, Dept Med, Bangkok, Thailand
[9] Queen Elizabeth 2 Hlth Sci Ctr, Dept Med, Halifax, NS, Canada
[10] Dalhousie Univ, Halifax, NS, Canada
来源
EUROPACE | 2020年 / 22卷 / 06期
关键词
Substrate; Less-established risk factors; Borderline risk factors; Atrial fibrillation hospitalization; Lone atrial fibrillation; Registry; 30-YEAR FOLLOW-UP; MANAGEMENT; COUNTRIES; PROGNOSIS; MORTALITY; DEATH;
D O I
10.1093/europace/euz360
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Data on patient characteristics, prevalence, and outcomes of atrial fibrillation (AF) patients without traditional risk factors, often labelled 'lone AF', are sparse. Methods and results: The RE-LY AF registry included 15 400 individuals who presented to emergency departments with AF in 47 countries. This analysis focused on patients without traditional risk factors, including age >= 60years, hypertension, coronary artery disease, heart failure, left ventricular hypertrophy, congenital heart disease, pulmonary disease, valve heart disease, hyperthyroidism, and prior cardiac surgery. Patients without traditional risk factors were compared with age- and region-matched controls with traditional risk factors (1:3 fashion). In 796 (5%) patients, no traditional risk factors were present. However, 98% (779/796) had less-established or borderline risk factors, including borderline hypertension (130-140/80-90mmHg; 47%), chronic kidney disease (eGFR<60mL/min; 57%), obesity (body mass index>30; 19%), diabetes (5%), excessive alcohol intake (>14 units/week; 4%), and smoking (25%). Compared with patients with traditional risk factors (n=2388), patients without traditional risk factors were more often men (74% vs. 59%, P<0.001) had paroxysmal AF (55% vs. 37%, P<0.001) and less AF persistence after 1 year (21% vs. 49%, P<0.001). Furthermore, 1-year stroke occurrence rate (0.6% vs. 2.0%, P=0.013) and heart failure hospitalizations (0.9% vs. 12.5%, P<0.001) were lower. However, risk of AF-related re-hospitalization was similar (18% vs. 21%, P=0.09). Conclusion: Almost all patients without traditionally defined AF risk factors have less-established or borderline risk factors. These patients have a favourable 1-year prognosis, but risk of AF-related re-hospitalization remains high. Greater emphasis should be placed on recognition and management of less-established or borderline risk factors.
引用
收藏
页码:870 / 877
页数:8
相关论文
共 50 条
  • [1] Alcohol Consumption and Cardiovascular Outcomes in Patients With Atrial Fibrillation; a RE-LY AF Registry Analysis
    Oraii, Alireza
    Kirabo, Faith
    Balasubramanian, Kumar
    Benz, Alexander P.
    Wong, Jorge A.
    McIntyre, William F.
    Conen, David
    Healey, Jeff S.
    CIRCULATION, 2022, 146
  • [2] Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis
    Pablo A. Mendoza
    William F. McIntyre
    Emilie P. Belley-Côté
    Jia Wang
    Ratika Parkash
    Clare L. Atzema
    Alexander P. Benz
    Jonas Oldgren
    Richard P. Whitlock
    Jeff S. Healey
    Journal of Thrombosis and Thrombolysis, 2022, 53 : 74 - 82
  • [3] Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis
    Mendoza, Pablo A.
    McIntyre, William F.
    Belley-Cote, Emilie P.
    Wang, Jia
    Parkash, Ratika
    Atzema, Clare L.
    Benz, Alexander P.
    Oldgren, Jonas
    Whitlock, Richard P.
    Healey, Jeff S.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (01) : 74 - 82
  • [4] Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry
    Johnson, Linda S.
    Jiang, Yuxuan
    Luu, Judy
    Van Gelder, Isabelle C.
    Atzema, Clare
    Conen, David
    Kloosterman, Marielle
    Armaganijan, Luciana
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Wallentin, Lars
    Johansson, Isabelle
    Mcintyre, William F.
    Oldgren, Jonas
    Healey, Jeffrey S.
    EUROPEAN HEART JOURNAL, 2024, 45 (26) : 2336 - 2340
  • [5] Clinical outcomes of atrial fibrillation patients receiving NSAIDs in the RE-LY trial
    Ezekowitz, M. D.
    Connolly, S. J.
    Fraessdorf, M.
    Brueckmann, M.
    Kreuzer, J.
    Oldgren, J.
    Reilly, P.
    Yusuf, S.
    Wallentin, L.
    EUROPEAN HEART JOURNAL, 2015, 36 : 862 - 862
  • [6] CLINICAL OUTCOMES OF ATRIAL FIBRILLATION PATIENTS RECEIVING DIGOXIN IN THE RE-LY® TRIAL
    Nagarakanti, Rangadham
    Connolly, Stuart
    Fraessdorf, Mandy
    Brueckmann, Martina
    Kreuzer, Joerg
    Reilly, Paul
    Oldgren, Jonas
    Yusuf, Salim
    Wallentin, Lars
    Ezekowitz, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 802 - 802
  • [7] Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study
    McAlister, Finlay A.
    Mian, Rajibul
    Oldgren, Jonas
    Wallentin, Lars
    Ezekowitz, Michael
    Yusuf, Salim
    Connolly, Stuart J.
    Healey, Jeff S.
    PLOS ONE, 2020, 15 (01):
  • [8] Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)
    Nagarakanti, Rangadham
    Wallentin, Lars
    Noack, Herbert
    Brueckmann, Martina
    Reilly, Paul
    Clemens, Andreas
    Connolly, Stuart J.
    Yusuf, Salim
    Ezekowitz, Michael D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (08): : 1204 - 1209
  • [9] Changes in Renal Function in Patients With Atrial Fibrillation An Analysis From the RE-LY Trial
    Boehm, Michael
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    Eikelboom, John W.
    Hohnloser, Stefan H.
    Reilly, Paul A.
    Schumacher, Helmut
    Brueckmann, Martina
    Schirmer, Stephan H.
    Kratz, Mario T.
    Yusuf, Salim
    Diener, Hans-Christoph
    Hijazi, Ziad
    Wallentin, Lars
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (23) : 2481 - 2493
  • [10] Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries The RE-LY Atrial Fibrillation Registry
    Oldgren, Jonas
    Healey, Jeff S.
    Ezekowitz, Michael
    Commerford, Patrick
    Avezum, Alvaro
    Pais, Prem
    Zhu, Jun
    Jansky, Petr
    Sigamani, Alben
    Morillo, Carlos A.
    Liu, Lisheng
    Damasceno, Albertino
    Grinvalds, Alex
    Nakamya, Juliet
    Reilly, Paul A.
    Keltai, Katalin
    Van Gelder, Isabelle C.
    Yusufali, Afzal Hussein
    Watanabe, Eiichi
    Wallentin, Lars
    Connolly, Stuart J.
    Yusuf, Salim
    CIRCULATION, 2014, 129 (15) : 1568 - 1576